Ab Studio Inc.
  1. Companies
  2. Ab Studio Inc.
  3. Articles
  4. ABS-INT-001 Internalizing Ab-ADC for ...

ABS-INT-001 Internalizing Ab-ADC for Cancer Therapeutics - Case Study

SHARE
Feb. 13, 2023
Courtesy ofAb Studio Inc.

Background

  • Growth factor X is a well-characterized target that is involved in multiple proliferation-related signal transduction pathways
  • Growth factor X expressed in multiple cancer types and therefore is an ideal target cancer therapies
Most popular related searches

Contact supplier

Drop file here or browse